MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 238 filers reported holding MIRATI THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.24 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $538,000 | -6.1% | 7,700 | -9.7% | 0.01% | -28.6% |
| Q2 2022 | $573,000 | +28.5% | 8,525 | +236.8% | 0.01% | -50.0% |
| Q3 2021 | $446,000 | -41.5% | 2,531 | -46.3% | 0.03% | +55.6% |
| Q2 2021 | $762,000 | -17.0% | 4,716 | -12.0% | 0.02% | -48.6% |
| Q1 2021 | $918,000 | -3.0% | 5,357 | +24.4% | 0.04% | -5.4% |
| Q4 2020 | $946,000 | +244.0% | 4,306 | +159.9% | 0.04% | +105.6% |
| Q3 2020 | $275,000 | -65.9% | 1,657 | -76.5% | 0.02% | -63.3% |
| Q2 2020 | $806,000 | – | 7,059 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $688,784,000 | 67.42% |
| Avoro Capital Advisors LLC | 4,535,000 | $996,067,000 | 17.15% |
| Darwin Global Management, Ltd. | 260,876 | $57,299,000 | 15.99% |
| Boxer Capital, LLC | 1,765,560 | $387,788,000 | 12.46% |
| Perceptive Advisors | 3,693,516 | $811,244,000 | 8.71% |
| Consonance Capital Management LP | 330,000 | $72,481,000 | 6.77% |
| EcoR1 Capital, LLC | 464,298 | $101,978,000 | 5.48% |
| Fairmount Funds Management LLC | 60,500 | $13,288,000 | 4.75% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 67,400 | $14,804,000 | 4.04% |
| RTW INVESTMENTS, LP | 1,054,364 | $231,581,000 | 3.88% |